z-logo
Premium
Screening of 25 compounds isolated from Phyllanthus species for anti‐human hepatitis B virus in vitro
Author(s) -
Huang RayLing,
Huang YuLing,
Ou JunChih,
Chen ChienChih,
Hsu FengLin,
Chang Chungming
Publication year - 2003
Publication title -
phytotherapy research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.019
H-Index - 129
eISSN - 1099-1573
pISSN - 0951-418X
DOI - 10.1002/ptr.1167
Subject(s) - phyllanthus , hbeag , hbsag , traditional medicine , euphorbiaceae , in vitro , biology , virology , pharmacognosy , virus , hepatitis b virus , medicine , biological activity , botany , biochemistry
Using an HBV‐producing cell line and inhibition of the expression of the HBsAg and HBeAg as antiviral indicators, a study was conducted on 25 compounds isolated from four Phyllanthus (Euphorbiaceae) plants, including P. amarus Schum. & Thonn., P. multiorus Willd., P. tenellus Roxb. and P. virgatus Forst. f.. It was found that niranthin ( 1 ), nirtetralin ( 3 ), hinokinin ( 5 ) and geraniin ( 13 ) at the non‐cytotoxic concentration of 50 µ m , suppressed effectively both HBsAg and HBeAg expression, with the highest inhibition at 74.3%, 45.3%; 69.6%, 33.9%; 68.1%, 52.3%; 32.1%, 46.6%, respectively. Of these, niranthin ( 1 ) showed the best anti‐HBsAg activity, while the most potent anti‐HBeAg activity was observed with hinokinin ( 5 ). Copyright © 2003 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom